Recently, we demonstrated cyclic alterations in GABA A receptor (GABA A R) subunit composition over the ovarian cycle correlated with fluctuations in progesterone levels. However, it remains unclear whether this physiological regulation of GABA A Rs is directly mediated by hormones. Here, we show that both ovarian and stress hormones are capable of reorganizing GABA A Rs by actions through neurosteroid metabolites. The cyclic alterations in GABA A Rs demonstrated in female mice can be mimicked with exogenous progesterone treatment in males or in ovariectomized females. Progesterone (5 mg/kg, twice daily) upregulates the expression of GABA A R ␦ subunits and enhances the tonic inhibition mediated by these receptors in dentate gyrus granule cells (DGGCs). These changes in males as well as ovarian cycle-induced changes in females can be blocked by finasteride, an antagonist of neurosteroid synthesis from progesterone. The altered GABA A R expression is unaffected by the progesterone receptor antagonist RU486 [mifepristone (11␤-[p-(dimethylamino) phenyl]-17␤-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one)], suggesting that neurosteroid synthesis and not progesterone receptor activation underlies the hormone-mediated effects on GABA A R expression. Neurosteroids can alter GABA A R expression on a rapid timescale, because GABA A R upregulation can be induced in brain slices maintained in vitro after a short (30 min) treatment with the neurosteroid 3␣,5␣-tetrahydrodeoxycorticosterone (THDOC) (100 nM). Consistent with these rapid alterations, acute stress, a condition known to quickly raise THDOC levels, within 30 min induces upregulation of GABA A R ␦ subunit expression and increase tonic inhibition in DGGCs. These results reveal that several physiological conditions characterized by elevations in neurosteroid levels induce a reorganization of GABA A Rs through the action of neurosteroids.
Introduction
During the ovarian cycle, when progesterone levels are elevated, GABA A receptors (GABA A Rs) become reorganized to decrease neuronal excitability (Maguire et al., 2005) . Similar ovarian cycle-related alterations in GABA A R expression take place in the periaqueductal gray matter (Griffiths and Lovick, 2005b) . The central question after observing any steroid hormone-related alterations in the CNS is whether the changes result from the direct activation of steroid hormone receptors (Li and O'Malley, 2003) or from the effects of the numerous steroid hormone metabolites, also referred to as neurosteroids, that are locally synthesized in the brain (Belelli and Lambert, 2005) . The ability to regulate GABA A R subunit composition would have tremendous therapeutic potential for a number of neurological disorders. Thus, we wanted to extend these studies to determine the mechanism of hormone-mediated GABA A R regulation.
Steroid hormones, such as progesterone and corticosterone, are known to exert a wide range of effects through both genomic mechanisms, primarily via activation of the nuclear hormone receptors, and nongenomic mechanisms, predominantly through action of neurosteroid metabolites on GABA A Rs (for review, see Li and O'Malley, 2003) . However, it remains unclear which of these mechanisms underlies changes in GABA A Rs mediated by changes in steroid hormone levels. Alterations in GABA A R subunit composition are correlated with fluctuations in steroid hormone levels (Li and O'Malley, 2003) , suggesting that ovarian cycle-linked changes in GABA A Rs may occur at the level of gene transcription involving activation of steroid hormone receptors. In vitro studies suggest that progesterone is capable of regulating the expression of a number of GABA A R genes (Pierson et al., 2005) . Although the requirement of progesterone receptor activation in the regulation of GABA A R gene expression has not been demonstrated (Pierson et al., 2005) , the ability of progesterone to induce changes in GABA A R gene expression in vitro, may take place in the absence of local neurosteroid synthesis.
Neurosteroids have been shown to alter GABA A R subunit expression directly (Shen et al., 2005) , which suggests that neurosteroid metabolites may be capable of regulating GABA A R expression independent of the progesterone receptor. However, it is unclear how neurosteroid metabolites regulate the expression of GABA A R subunits. Neurosteroids have been shown to regulate the activity of PKC (protein kinase C)-mediated phosphorylation of GABA A Rs (Brussaard and Koksma, 2003) and the surface expression of GABA A Rs depends on GABA A R phosphorylation (for review, see Kittler and Moss, 2003) , suggesting that neurosteroids themselves could regulate the surface expression of GABA A R subunits.
The goal of this study was to examine the mechanism of steroid hormone-mediated regulation of GABA A Rs. Gaining insight into the mechanisms of GABA A R regulation would have tremendous therapeutic potential in the treatment of numerous neurological and psychiatric disorders. Here, we show that the steroid hormone-mediated regulation of GABA A Rs requires neurosteroid synthesis but not activation of steroid hormone receptors, revealing a direct regulatory action of neurosteroids on GABA A Rs.
Materials and Methods
Animal handling. We have taken steps to minimize the stress of the animals in each experimental group before anesthesia. Each animal was transferred to the dissection area in its home cage at least 2 h before anesthesia to acclimatize the animals to the new environment. To anesthetize the animals, the air around their home cage was gradually exchanged to a mixture of air plus a volatile anesthetic (halothane), thus avoiding any direct handling of unanesthetized animals. The CO 2 exposure was performed in a manner similar to the volatile anesthetic administration. When the animal was fully anesthetized, it was removed from the home cage and rapidly decapitated. Maintaining the animals in their home cages and acclimatizing them before anesthesia substantially decreased the amount of stress the animals endure. All animals were handled identically, apart from the experimental manipulations.
Whole-cell recordings. Whole-cell patch-clamp recordings were performed on dentate gyrus granule cells (DGGCs) in 350-m-thick coronal hippocampal slices prepared from adult (3-4 months of age) C57BL/6 mice. The slices were perfused with normal artificial CSF (nACSF) (in mM: 126 NaCl, 2.5 KCl, 2 CaCl 2 , 1-2 MgCl 2 , 1.25 NaHPO 4 , 26 NaHCO 3 , and 10 -25 [SCAP]D-glucose, bubbled with 95% O 2 and 5% CO 2 , pH 7.3-7.4) containing 3-5 mM kynurenic acid and 5 M GABA (Sigma, St. Louis, MO) as described previously (Stell et al., 2003; Wei et al., 2004) . Intracellular recording solution containing the following (in mM): 140 CsCl, 1 MgCl 2 , 10 HEPES, and 4 Na-ATP, pH 7.25, 280 -290 mOsm, and electrodes with DC resistance of 2-5 M⍀ were used for all recordings. 2-(3-Carboxypropyl)-3-amino-6-(4-methoxyphenyl)pyridazinium bromide (SR95531) (Ͼ100 M SR95531; Sigma) was added to the external recording solution where indicated. For the in vitro 3␣,5␣-tetrahydrodeoxycorticosterone (THDOC) experiments, immediately after preparation, the slices were placed in ACSF containing 100 nM THDOC for 30 min. After 30 min in THDOC, the slices were incubated in nACSF for 30 min up to 2 h. Whole-cell patch-clamp recordings were then performed in slices at 30 min intervals. Data analysis was performed as described previously (Nusser and Mody, 2002; Stell and Mody, 2002; Stell et al., 2003) . Briefly, the mean current was measured during 5 ms epochs collected every 100 ms throughout the experiment. A Gaussian fit to these points gave the mean current during a period of 10 -30 s before the addition of SR95531 and after SR95531 addition. The difference between these two values was considered to be the tonic current. Statistical significance was determined using Student's t test.
Western blot analysis. Western blot analysis was performed as described previously (Maguire et al., 2005) . The hippocampus was rapidly dissected out from adult mice and homogenized in a buffer containing 50 mM Tris-HCl, 5 mM EDTA, 10 mM EGTA, and 0.5 mM dithiothreitol, in the presence of protease inhibitors (Complete Mini; Roche, Indianapolis, IN). The membrane fraction was isolated and protein concentrations were determined using the DC Protein Assay (Bio-Rad, Hercules, CA). A total of 100 g of total protein was subjected to SDS-PAGE and transferred to a nitrocellulose membrane (Amersham Biosciences, Piscataway, NJ), blocked in 10% nonfat milk, and probed with a polyclonal antibody specific for the GABA A R ␦ (1:5000; a gift from Dr. W. Sieghart, University of Vienna, Vienna, Austria). The blots were incubated with peroxidase-labeled anti-rabbit IgG (1:2000; Vector Laboratories, Burlingame, CA), and immunoreactive proteins were visualized using enhanced chemiluminescence (Amersham Biosciences). Optical density measurements were determined using the NIH Image J software. Statistical significance was determined using ANOVA.
Acute stress paradigm. Adult male mice (3-4 months of age) remained in their home cage, the air around the home cage was then replaced for 2 min with a gas mixture containing 21% O 2 , 44% N 2 , and 35% CO 2. After 2 min, the home cage was removed from the CO 2 chamber, and the animals were allowed to recover for 30 min before experimentation.
Electrode implant and electroencephalogram recordings. Age-matched adult C57BL/6 mice (Harlan, Indianapolis, IN) were anesthetized with 100 mg/kg ketamine, 5.2 mg/kg xylazine, and 1.0 mg/kg acepromazine according to a protocol approved by the University of California, Los Angeles, Chancellor's Animal Research Committee. A lengthwise incision was made along the scalp, and a small burr hole was made 2.2 mm posterior to bregma and 1.7 mm lateral to the midline. A micromanipulator was used to place a hippocampal depth electrode (Plastics One, Roanoke, VA) in the hippocampus at a depth of 2.0 mm. The electrode was fixed to the skull using dental cement, and the animal was allowed to recover for 48 h before recordings were undertaken. Electroencephalogram (EEG) recordings were started 10 min before an intraperitoneal injection of 15 mg/kg kainic acid (Sigma) and continued for 2 h after the injection. Recordings were low-pass filtered at 200 Hz and sampled at 1 kHz using an in-house Labview-based (National Instruments, Austin, TX) software. Seizure events were defined as changes in the amplitude of electrographic activity and identified by consistent changes in the power of the fast Fourier transform of the EEG. The "percentage time seizing" was calculated as the cumulative time of all seizure activity divided by 120 min (the duration of the recording period). Statistical analysis was done by ANOVA, setting a level of significance of p Ͻ 0.05.
Results
Nuclear progesterone receptors are not involved in the control of GABARs, tonic inhibition, and neuronal excitability during the ovarian cycle To determine whether progesterone acts via progesterone receptors or progesterone metabolites to mediate the changes in GABA A Rs associated with the ovarian cycle, we analyzed changes in GABA A Rs in female cycling mice treated with either the progesterone receptor antagonist, mifepristone (11␤-[p-(dimethylamino)phenyl]-17␤-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one) (RU486) (50 mg/kg) (Borowicz et al., 2002; Xu et al., 1998) , or the neurosteroid synthesis inhibitor, finasteride (100 mg/kg) (Kokate et al., 1999) . Cycling females were treated with either RU486 or finasteride twice daily for 2 d, beginning at estrus and continuing through diestrus. GABA A R expression and function were then assessed, after 2 d of consecutive treatment, at late diestrus. Finasteride treatment prevents GABA A R ␦ subunit upregulation during diestrus ( Fig. 1) , suggesting that neurosteroid synthesis is required for GABA A R regulation. The increase in GABA A R ␦ subunit expression observed during diestrus (0.64 Ϯ 0.01 OD/100 g total protein) was blocked in mice treated with finasteride from estrus through diestrus (0.53 Ϯ 0.01 OD/100 g total protein). The progesterone receptor antagonist, RU486, and the estrogen receptor antagonist, tamoxifen (2 mg/kg), had no significant effects on GABA A R ␦ subunit regulation over the ovarian cycle (0.62 Ϯ 0.01 and 0.62 Ϯ 0.02 OD/100 g total protein, respectively) ( Fig. 1 ) (n ϭ 4 -7 mice for each group; p Ͻ 0.05). These results suggest that neurosteroid synthesis is required for regulating GABA A R expression during the ovarian cycle. These data also demonstrate that progesterone receptor activation does not play a role in the ovarian cycle-dependent regulation of GABA A Rs. Furthermore, finasteride treatment from estrus through diestrus blocks the increase in GABA A R ␦ subunit-mediated tonic inhibition observed in DGGCs during diestrus (Fig. 2) . The increased GABAergic tonic inhibition in DGGCs during diestrus (36.2 Ϯ 5.2 pA) compared with estrus (8.1 Ϯ 2.6 pA) is significantly reduced by in vivo finasteride treatment (16.0 Ϯ 2.8 pA) (Fig. 2 ) (n ϭ 24 cells; n ϭ 9 mice; p Ͻ 0.05). RU486 treatment of the animals at diestrus (20.6 Ϯ 2.8 pA) had no significant effect on the tonic current measured in DGGCs compared with untreated controls (22.3 Ϯ 1.3 pA) ( Fig. 2 ) (n ϭ 21 cells; n ϭ 8 mice; p Ͼ 0.05), which is still significantly larger than untreated estrous mice (6.6 Ϯ 2.3 pA) ( Fig. 2 ) (n ϭ 21 cells; n ϭ 8 mice; p Ͻ 0.05).
To determine the effects of blocking neurosteroid synthesis on neuronal excitability, female mice were treated for 2 consecutive days, beginning at estrus through diestrus with either finasteride, RU486, or tamoxifen. After 2 d of treatment, seizure susceptibility in response to 15 mg/kg kainic acid was analyzed at diestrus by hippocampal depth electrode EEG recordings. Diestrous mice exhibit a decrease in the cumulative percentage time seizing in the 2 h after kainic acid administration (45.2 Ϯ 6.8%) compared with estrous mice (81.7 Ϯ 2.7%) (Fig. 3) , which is blocked with finasteride (77.3 Ϯ 3.7%) and RU486 (74.1 Ϯ 2.0%) but is unaffected by tamoxifen (45.2 Ϯ 1.0%) (Fig. 3 ) (n ϭ 4 -7 mice for each group; p Ͻ 0.05). The effect of RU486 on seizure susceptibility was surprising in light of the lack of RU486 effect on GABA A R subunit expression and tonic inhibition. These pharmacological results are consistent with the idea that neurosteroid synthesis is required for the ovarian cycle-linked changes in neuronal excitability.
Changes observed during the ovarian cycle can be mimicked by progesterone administration to males and ovariectomized females Additional evidence that the changes in GABA A Rs are mediated by progesterone metabolites comes from the evidence that the changes in GABA A Rs observed over the ovarian cycle of female mice can be mimicked in male mice and ovariectomized females treated with progesterone. Male mice were treated with 5 mg/kg twice daily for 2 d, which results in plasma levels of progesterone analogous to that of diestrous females (data not shown), induced an increase in GABA A R ␦ subunit expression (0.63 Ϯ 0.02 OD/ 100 g total protein) compared with untreated controls (0.49 Ϯ 0.02 OD/100 g total protein) (Fig. 4) (n ϭ 4 -8 mice for each group; p Ͻ 0.05). Consistent with an upregulation of GABA A R ␦ subunit expression, progesterone administration to ovariectomized females increases the tonic GABAergic inhibition in DGGCs (70.1 Ϯ 10.01 pA) compared with untreated ovariectomized controls (23.0 Ϯ 5.32 pA) (Fig. 4) (n ϭ 3 mice for each group; p Ͻ 0.05). Similar to the regulation of GABA A Rs in cycling female mice, the increase in GABA A R ␦ subunit expression by progesterone (0.63 Ϯ 0.02 OD/100 g total protein) compared with untreated males (0.49 Ϯ 0.02 OD/100 g total protein) was blocked by finasteride (100 mg/kg) (0.44 Ϯ 0.01 OD/100 g total protein) (Fig. 4) (n ϭ 4 -8 mice for each group; p Ͻ 0.05), but not by RU486 treatment (50 mg/kg) (0.58 Ϯ 0.01 OD/100 g total protein) (Fig. 4) (n ϭ 4 -8 mice for each group; p Ͼ 0.05). These results further demonstrate the requirement of neurosteroid synthesis in mediating the regulation of GABA A Rs by progesterone.
Males treated with progesterone exhibit a decrease in the cumulative percentage time seizing per 2 h after kainic acid administration (32.1 Ϯ 2.9%) compared with untreated males (66.3 Ϯ 8.9%) (Fig. 5) (n ϭ 4 -6 mice for each group; p Ͻ 0.05). This anticonvulsant action of progesterone in males is also blocked by treatment with finasteride (79.3 Ϯ 6.6%), but is unaltered by administration of RU486 (27.3 Ϯ 6.1%) (Fig. 5) (n ϭ 4 -8 mice for each group), further suggesting that the effects of progesterone on GABA A R regulation and excitability are mediated by neurosteroid metabolites of progesterone.
Rapid changes in GABA A R expression and function induced by stress hormones
We have demonstrated that there are ovarian hormone-mediated changes in GABA A R expression and function mediated by neurosteroid metabolites. To determine whether changes in GABA A Rs are unique to conditions of elevated ovarian hormone levels, we analyzed the changes in GABA A Rs associated with elevations in stress hormones after a single acute stressful episode. Mice were acutely stressed (2 min of CO 2 exposure) (Barbaccia et al., 1994) , and GABA A R expression was analyzed by Western blot in brain tissue prepared 30 min after the acute stress episode. Acute stress causes an increase in GABA A R ␦ subunit expression compared with controls ( Fig. 6 A, C) . GABA A R ␦ subunit expression is increased after CO 2 stress (1.15 Ϯ 0.02 OD/100 g total protein) compared with unstressed control mice (0.31 Ϯ 0.02 OD/100 g total protein) (Fig. 6C ) (n ϭ 4 mice for each group; p Ͻ 0.05). Consistent with an increase in GABA A R ␦ subunit expression, we also find an increase in tonic inhibition mediated by these receptors in DGGCs of mice exposed to the acute CO 2 stress episode compared with controls ( Fig. 6 B, D) . Tonic inhibition is increased in DGGCs in mice exposed to 2 min of CO 2 stress (50.2 Ϯ 7.6 pA) compared with controls (22.4 Ϯ 3.9 pA) (Fig. 6B,D) (n ϭ 26 cells; n ϭ 8 mice; p Ͻ 0.05). There is no significant difference in the frequency, peak amplitude, or decay time of spontaneous IPSCs (sIPSCs) in mice exposed to CO 2 (1.7 Ϯ 0.4 Hz; 43.7 Ϯ 4.3 pA; 11.8 Ϯ 0.9 ms) compared with controls (1.3 Ϯ 0.3 Hz; 46.4 Ϯ 2.7 pA; 15.3 Ϯ 0.7 ms) (Fig. 6 D) (n ϭ 26 cells; n ϭ 8 mice; p Ͼ 0.05). These results demonstrate alterations in GABA A R structure and function after acute stress attributable to elevations in neurosteroid levels. Lasting changes in tonic inhibition after a transient acute treatment with the stress-related neurosteroid derivative THDOC To determine whether the changes in GABA A R structure and function after stress are attributable to the action of neurosteroid metabolites, we analyzed the effect of a transient exposure of brain slices to 100 nM THDOC on GABAergic inhibition in vitro. Whole-cell patch-clamp recording performed on acute hippocampal slices exposed to THDOC (30 min) exhibited a significant increase in tonic inhibition in DGGCs at all times up to 2 h after THDOC washout (Fig. 7) . The tonic inhibition in DGGCs was increased after THDOC treatment at 30 min of nACSF washout (103.1 Ϯ 27.2 pA), 1 h (151.0 Ϯ 26.2 pA), 1.5 h (106.6 Ϯ 20.1 pA), and 2 h (126.5 Ϯ 54.8 pA) compared with untreated slices (22.4 Ϯ 3.9 pA) (Fig. 7) (n ϭ 28 cells; n ϭ 10 mice; p Ͻ 0.05). These results suggest that the changes in GABA A Rs (i.e., the increase in GABA A R ␦ subunit expression) induced by neurosteroid exposure are maintained for at least 2 h after washout with nACSF. There are no changes in the frequency (2.2 Ϯ 0.4 vs 1.5 Ϯ 0.4 Hz), peak amplitude (45.4 Ϯ 3.9 vs 46.5 Ϯ 2.7 pA), or decay time (15.2 Ϯ 1.3 vs 15.4 Ϯ 0.7 ms) of the spontaneous IPSCs at any time after THDOC treatment compared with control untreated slices (Fig. 7) (n ϭ 28 cells; n ϭ 10 mice; p Ͼ 0.05).
To evaluate the washout of THDOC from slices, we performed whole-cell patch-clamp recordings on dentate DGGCs and perfused 100 nM THDOC onto the slices for 5 min followed by a wash with normal ACSF for 15 min. The sIPSC properties were measured before the addition of THDOC, during perfusion of THDOC, and 15 min after the washout of THDOC from the slices. A 15 min THDOC washout was sufficient to remove the effect of THDOC on sIPSCs (average Ϯ SEM amplitude, before, 42.7 Ϯ 6.5 pA; during, 61.6 Ϯ 7.9 pA; after, 32.0 Ϯ 16.0 pA; average Ϯ SEM decay time constant, before, 15.8 Ϯ 0.9 ms; during, 20.2 Ϯ 1.0 ms; after, 17.3 Ϯ 1.0 ms; n ϭ 10). These findings demonstrate that allowing for 30 -120 min of THDOC washout is sufficient to remove THDOC from the slice, and thus the changes we observe in tonic inhibition must be attributable to rapid changes in GABA A Rs rather than an incomplete washout of the neurosteroid from the slices.
Discussion
In the present study, we demonstrate that neurosteroid metabolites are capable of regulating the expression, and thereby function, of GABA A Rs. Here, we show that a condition that is characterized by elevated levels of neurosteroids induces altered expression of GABA A Rs, such that the ␦ subunit, which is mainly responsible for neurosteroid modulation, is upregulated and the tonic inhibition mediated by these receptors is enhanced, thus decreasing neuronal excitability. Regulation of GABA A Rs by hormones has been presumed to be either direct allosteric modulation of GABA A Rs by neurosteroid metabolites or longer-term structural changes mediated by hormone receptor activation. Our results indicate that neurosteroids themselves are capable of . Acute stress increases GABA A R ␦ subunit expression and tonic inhibition. A, Representative immunoblots with antibodies to GABA A R ␦ subunits of total membrane hippocampal protein from two unstressed control male mice and two mice male mice exposed to 2 min of CO 2 stress. B, Representative recordings from control unstressed male mice and male mice subjected to 2 min of CO 2 stress. C, The bar graphs of average optical densities of Western blots and average tonic current demonstrate the upregulation of the GABA A R ␦ subunit expression and increased tonic inhibition after acute stress compared with control. The asterisk denotes significance ( p Ͻ 0.05). Error bars indicate SEM. D, Representative recordings from control unstressed males and males exposed to 2 min of CO 2 stress. The inset shows superimposed averaged sIPSCs recorded in DGGCs from control unstressed and males exposed to 2 min of CO 2 stress.
Tonic Current (pA) inducing alterations in GABA A Rs and may mediate changes in neuronal excitability associated with conditions of elevated neurosteroid levels (i.e., stress). These results provide new insight into the possible mechanisms responsible for regulation of GABA A Rs.
Neurosteroid regulation of GABA A Rs
Steroid hormones, both progesterone and estrogen, have been shown to play a role in synaptic plasticity in many different brain regions of several species (Terasawa and Timiras, 1968; Kawakami et al., 1969; Teyler et al., 1980; Gould et al., 1990; Woolley and McEwen, 1992) . However, only one study has addressed the mechanism of steroid hormone-mediated synaptic plasticity. Alterations in spine density over the ovarian cycle are mediated by progesterone receptor activation (Woolley and McEwen, 1993) but also require activation of NMDA receptors (Woolley and McEwen, 1994) , suggesting that activation of neurotransmitter receptors may be involved in the regulation of neuronal function by steroids. Based on our findings, neurosteroid metabolites, presumably acting at ␦ subunit-containing GABA A Rs, are also required for steroid hormone-mediated regulation of GABA A Rs. Neurosteroids are known to be potent allosteric modulators of GABA A Rs, but how is it that neurosteroids may alter GABA A R levels on the surface of nerve cells? Previous studies have shown that exogenous neurosteroid administration alters GABA A R subunit expression (Shen et al., 2005) , suggesting that these metabolites of steroid hormones can regulate GABA A Rs. Blocking neurosteroid synthesis, using finasteride, prevents changes in GABA A R mRNA levels observed during pregnancy (Concas et al., 1998) , suggesting that alterations in GABA A Rs are not a consequence of progesterone acting on progesterone receptors but rather of neurosteroid action at the steroid recognition site on GABA A receptors Concas et al., 1998) . Neurosteroid-mediated changes in GABA A receptor subunit expression are not limited to progesterone-derived neurosteroids, such as allopregnanolone. Corticosterone induces complex changes in GABA A receptor pharmacology . Our data support the hypothesis that neurosteroid metabolites may directly alter GABA A receptor subunit expression in the neuronal membrane independent of steroid hormone receptor activation.
The fact that steroid hormone-associated alterations in GABA A Rs are mediated by neurosteroid metabolites and not by activation of steroid hormone receptors is further suggested from the similar regulation in GABA A Rs between males and females. There is no evidence for any gender differences in the distribution of GABA A Rs or hormone receptors (Lauber et al., 1991; Simerly and Young, 1991) ; thus, if GABA A R subunit regulation is mediated by neurosteroids, gender differences should not affect GABA A R regulation. Consistent with the lack of gender differences in neurosteroid regulation of GABA A Rs, there are no gender differences in their neurosteroid sensitivity in a variety of brain regions (Wilson and Biscardi, 1997) .
It remains unclear how neurosteroid metabolites, acting independently of steroid hormone receptors, are able to induce changes in GABA A receptor subunit expression. Neurosteroids are synthesized in hippocampal principal neurons, not interneurons (Agis-Balboa et al., 2006) , by the enzymatic metabolism of steroid precursors. These neurosteroids can then act in either a paracrine or autocrine manner on GABA A Rs to regulate excitability. Release of neurosteroids specifically by principal glutamatergic neurons in the hippocampus (Agis-Balboa et al., 2006), including DGGCs, suggests that the neurosteroid-mediated changes in GABA A Rs may be attributable to local neurosteroid synthesis and release from principal neurons acting on themselves or on other nearby cells. The GABA A R ␦ subunit is mainly localized in the DGGC dendrites (Wei et al., 2003) and has similarities to those proteins known to undergo dendritic targeting and local translation (Steward and Schuman, 2001) . Therefore, its function may be regulated by dendritic mRNA synthesis. The expression of GABA A Rs has been shown to be modulated by GABA A R phosphorylation (for review, see Kittler and Moss, 2003) . The impact of phosphorylation on GABA A R activity has been described primarily for GABA A R subunits mediating the phasic component of GABAergic inhibition (Essrich et al., 1998; Brandon et al., 2000 Brandon et al., , 2001 ) (for review, see Kittler and Moss, 2003) . However, the role of phosphorylation in the regulation of extrasynaptic GABA A Rs is not clear, but phosphorylation can alter the neurosteroid sensitivity of GABA A Rs at synapses (Brussaard et al., 2000; Fancsik et al., 2000; Hodge et al., 2002; Harney et al., 2003) . Another potential mechanism for the neurosteroiddependent increase in GABA A R expression is to interfere with the dynamin-dependent endocytosis of the receptors (Bogdanov et al., 2006) .
RU486 and excitability
We have observed gender differences in the effect of RU486 on neuronal excitability. RU486 did not have a significant effect on neuronal excitability in males but increased excitability in cycling females. These data suggest that antagonists at progesterone receptors have different effects in male versus female animals. However, we do not see a difference in the effect of RU486 on the regulation of GABA A Rs, suggesting that perhaps the gender differences in excitability are attributable to other effects of RU486 not directly related to blocking progesterone receptor activation. An indirect role of RU486 in the observed gender differences on seizure susceptibility is supported by the reported lack of differences in progesterone receptor expression in the CNS of male and female mice. The reason for the increased excitability induced by RU486 in females remains to be determined, but may be attributable to its potential effect of increasing estrogen levels shown in pregnant females treated with RU486 (Fang et al., 1997) . Estrogen is known to increase excitability in response to kainic acid administration (Woolley, 2000) . A proconvulsant effect of elevated estrogen in females treated with RU486 may underlie the observed differences in seizure susceptibility between males and females treated with RU486. Nevertheless, according to our findings, blocking the progesterone receptor with RU486 does not have an effect on the steroid hormone regulation of GABA A Rs.
Stress
Stress is known to cause elevations in neurosteroid levels, in particular a derivative of corticosterone, the neurosteroid THDOC (Purdy et al., 1991; Barbaccia et al., 1996b Barbaccia et al., , 2001 McEwen, 2002; Reddy and Rogawski, 2002) , as well as allopregnanolone (Barbaccia et al., 1996a ) (for review, see Reddy, 2003) . Several studies, relying heavily on binding and uptake assays, have demonstrated changes in GABA A R function after stress (Skerritt et al., 1981; Schwartz et al., 1987; Akinci and Johnston, 1993; Serra et al., 2000) . However, the impact of increased stress-related neurosteroid levels on the expression of specific GABA A Rs was previously unknown. The correlation between elevated levels of neurosteroids over the ovarian cycle and altered expression of GABA A R subunits, specifically upregulation of GABA A R ␦ subunit expression (Griffiths and Lovick, 2005a; Maguire et al., 2005) , appears to be analogous with the effect of elevated neurosteroid levels after stress (Fig. 6 A, C) .
Acute versus chronic stress have opposite effects on GABAergic function. Acute stress increases GABA A R-mediated chloride influx (Schwartz et al., 1987) , whereas a decrease in GABAergic function is associated with chronic stress (Serra et al., 2000) . In addition, the effects of neurosteroids on GABA A R subunit expression also appear to have a bimodal effect, such that shortterm exposure as well as withdrawal from neurosteroids appear to exert similar effects (Sundstrom-Poromaa et al., 2002) . This bimodal action of neurosteroids on GABA A Rs may underlie the profound differences in acute versus chronic stress on neuronal excitability. Chronic stress is a well known seizure trigger (Frucht et al., 2000; Chadda and Devaud, 2004) ; however, counterintuitive to the proconvulsant effect of chronic stress, acute stress has been shown to be anticonvulsant (Reddy and Rogawski, 2002) . Acute stress enhances the binding of GABA agonists (Skerritt et al., 1981; Akinci and Johnston, 1993) and decreases seizure susceptibility (Pericic et al., 2001) , which is correlated with elevated neurosteroid levels (Reddy, 2003) . However, until now, additional analysis of the role of specific GABA A R subunits in the stress-associated decreased seizure susceptibility was not available.
We have shown that elevations in neurosteroid levels associated with an acute stressful episode induce alterations in GABA A Rs, which may function to maintain the balance between excitation and inhibition after stress. The duration of neurosteroid exposure and the rate of decline of neurosteroid levels may be critical for the regulation of GABA A Rs. The key to the regulation may be a relatively rapid rise and fall in neurosteroid levels, because long-term exposure to positive allosteric modulators such as benzodiazepines, alcohol, and even neurosteroids result in a downregulation of receptor function (Bateson, 2002; Krystal et al., 2006; Reddy, 2006) . Disruption in the regulation of GABA A Rs in response to stress may underlie the stress-induced exacerbation of many psychiatric and neurological disorders. The upregulation of GABA A R ␦ subunit expression after an acute stressful episode may be a protective mechanism to prevent an imbalance in neuronal excitability. Our results demonstrate that, in addition to the direct allosteric modulation of GABA A Rs, neurosteroids also regulate GABA A Rs on a longer timescale by altering the expression of specific GABA A R subunits. This may have implications on the clinical use of neurosteroid synthesis inhibitors such as finasteride (Propecia), because certain neurological disorders related to steroid hormone changes may be worsened by finasteride treatment (Herzog and Frye, 2003) .
